Advancing medicines of future

Pipeline

Candidate	MOA	Indication	Route	Stage
NORA520 [505(b)(2)]	GABA_A PAM	Postpartum Depression, PPD	Oral	Phase 2
		Major Depressive Disorder, MDD	Oral	Phase 1
		Essential Tremor, ET	Oral	Preclinical
		Orphan Epilepsy*	Oral	Discovery
		General Anxiety Disorder, GAD	Oral (ER)	Discovery
		Bipolar	Oral (ER)	Discovery

Candidate	MOA	Indication	Route
NORA520 [505(b)(2)]	GABA_A PAM	Postpartum Depression, PPD	Oral
		Major Depressive Disorder, MDD	Oral
		Essential Tremor, ET	Oral
		Orphan Epilepsy*	Oral
		General Anxiety Disorder, GAD	Oral (ER)
		Bipolar	Oral (ER)

*For example: lennox-gastaut syndrome; Dravet Syndrome; CKDL5 deficiency disorder …etc